Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan;33(1):3-14.
doi: 10.1007/s11695-022-06332-1.

2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery

Affiliations

2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) Indications for Metabolic and Bariatric Surgery

Dan Eisenberg et al. Obes Surg. 2023 Jan.

Erratum in

Abstract

MAJOR UPDATES TO 1991 NATIONAL INSTITUTES OF HEALTH GUIDELINES FOR BARIATRIC SURGERY: Metabolic and bariatric surgery (MBS) is recommended for individuals with a body mass index (BMI) >35 kg/m2, regardless of presence, absence, or severity of co-morbidities.MBS should be considered for individuals with metabolic disease and BMI of 30-34.9 kg/m2.BMI thresholds should be adjusted in the Asian population such that a BMI >25 kg/m2 suggests clinical obesity, and individuals with BMI >27.5 kg/m2 should be offered MBS.Long-term results of MBS consistently demonstrate safety and efficacy.Appropriately selected children and adolescents should be considered for MBS.(Surg Obes Relat Dis 2022; https://doi.org/10.1016/j.soard.2022.08.013 ) © 2022 American Society for Metabolic and Bariatric Surgery. All rights reserved.

Keywords: ASMBS; Criteria; IFSO; Indications; Metabolic and bariatric surgery; Obesity.

PubMed Disclaimer

Comment in

References

    1. Gastrointestinal surgery for severe obesity. Consens Statement 1991;9(1):1–20. - PubMed
    1. Ogden CL, Carroll MD, Kit BK, Flegal KL. Prevalence of childhood and adult obesity in the United States 2011–12. JAMA. 2014;311(8):806–814. doi: 10.1001/jama.2014.732. - DOI - PMC - PubMed
    1. World Health Organization (WHO) [monograph on the Internet]. Geneva: World Health Organization; 2002 [cited 2022 Mon D]. Available from: https://www.who.int/publications/i/item/9241562072.
    1. Gossman H, Butsch WS, Jastreboff AM. Treating the chronic disease of obesity. Med Clin N Am. 2021;105(6):983–1016. doi: 10.1016/j.mcna.2021.06.005. - DOI - PubMed
    1. Kawai T, Autieri MV, Scalia R. Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol. 2021;320(3):C375–C391. doi: 10.1152/ajpcell.00379.2020. - DOI - PMC - PubMed